Jan 13, 2026 07:24AM Nyxoah (NYXH) Reiterated at Buy by Stifel: €4.4MM 1Q26 Revenue Guided

Nov 14, 2025 08:12AM Nyxoah SA (NYXH) PT Lowered to $9 at Piper Sandler

Nov 14, 2025 02:28AM Nyxoah secures up to $77 million in financing for US commercialization

Nov 13, 2025 04:37PM Nyxoah secures up to $77 million in financing for US expansion

Aug 19, 2025 06:02AM Oppenheimer Reiterates Outperform Rating on Nyxoah SA (NYXH)

Aug 19, 2025 05:03AM Stifel Reiterates Buy Rating on Nyxoah SA (NYXH)

Aug 11, 2025 09:13AM Nyxoah stock surges after FDA approves Genio system for sleep apnea

Aug 11, 2025 07:00AM Cantor Fitzgerald Reiterates Overweight Rating on Nyxoah SA (NYXH)

Jul 28, 2025 08:35AM Stifel Reiterates Buy Rating on Nyxoah SA (NYXH)

Jun 13, 2025 08:26AM Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names

May 19, 2025 06:44AM Cantor Fitzgerald Reiterates Overweight Rating on Nyxoah SA (NYXH)

Apr 21, 2025 07:57AM Nyxoah SA (NYXH) PT Lowered to $14 at Stifel

Mar 31, 2025 06:32AM Oppenheimer Reiterates Outperform Rating on Nyxoah SA (NYXH)

Mar 28, 2025 07:35AM Stifel Reiterates Buy Rating on Nyxoah SA (NYXH)

Mar 17, 2025 07:38AM Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer

Mar 14, 2025 09:00AM Nyxoah SA (NYXH) PT Lowered to $15 at Stifel

Mar 14, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Nyxoah SA (NYXH)

Dec 23, 2024 09:58AM Piper Sandler on HGNS Devices Following Eli Lilly's Zepbound FDA Indication Approval

Nov 7, 2024 06:19AM Oppenheimer Reiterates Outperform Rating on Nyxoah SA (NYXH)

Oct 14, 2024 06:46AM Nyxoah SA (NYXH) PT Lowered to $17 at H.C. Wainwright

Sep 30, 2024 07:27AM H.C. Wainwright Reiterates Buy Rating on Nyxoah SA (NYXH)

Sep 30, 2024 06:04AM Stifel Reiterates Buy Rating on Nyxoah SA (NYXH)

Jul 2, 2024 06:39AM H.C. Wainwright Reiterates Buy Rating on Nyxoah SA (NYXH)